ACR Convergence 2022

November 10-14, 2022. Philadelphia, PA.

View by Number View by Title View Sessions

View by Date

Saturday, November 12, 2022

11:30AM-1:00PM: Plenary I

1:00PM-3:00PM: B Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster

1:00PM-3:00PM: Health Services Research Poster I: Lupus, RA, Spondyloarthritis and More

1:00PM-3:00PM: Healthcare Disparities in Rheumatology Poster

1:00PM-3:00PM: Miscellaneous Rheumatic and Inflammatory Diseases Poster I

1:00PM-3:00PM: Muscle Biology, Myositis and Myopathies Poster I

1:00PM-3:00PM: Osteoarthritis and Joint Biology – Basic Science Poster

1:00PM-3:00PM: Patient Education/Community Programs Poster

1:00PM-3:00PM: Patient Outcomes, Preferences, and Attitudes Poster I

1:00PM-3:00PM: Patient Perspectives Poster

1:00PM-3:00PM: Pediatric Rheumatology – Basic Science Poster

1:00PM-3:00PM: Professional Education Poster

1:00PM-3:00PM: RA – Animal Models Poster

1:00PM-3:00PM: RA – Diagnosis, Manifestations, and Outcomes Poster I

1:00PM-3:00PM: RA – Treatment Poster I

1:00PM-3:00PM: SLE – Diagnosis, Manifestations, and Outcomes Poster I: Diagnosis

1:00PM-3:00PM: SLE – Treatment Poster I

1:00PM-3:00PM: Spondyloarthritis Including PsA – Diagnosis, Manifestations, and Outcomes Poster I

1:00PM-3:00PM: Spondyloarthritis Including PsA – Treatment Poster I: AxSpA

1:00PM-3:00PM: Vasculitis – ANCA-Associated Poster I: Epidemiology, Outcomes, and Classification

1:00PM-3:00PM: Vasculitis – Non-ANCA-Associated and Related Disorders Poster I: Giant Cell Arteritis

5:00PM-6:00PM: Patient Perspectives

Sunday, November 13, 2022

9:00AM-10:30AM: Antiphospholipid Syndrome Poster

9:00AM-10:30AM: Cytokines and Cell Trafficking Poster

9:00AM-10:30AM: Epidemiology and Public Health Poster I

9:00AM-10:30AM: Health Services Research Poster II

9:00AM-10:30AM: Immunological Complications of Medical Therapy Poster

9:00AM-10:30AM: Infection-related Rheumatic Disease Poster

9:00AM-10:30AM: Miscellaneous Rheumatic and Inflammatory Diseases Poster II

9:00AM-10:30AM: Orthopedics, Low Back Pain, and Rehabilitation Poster

9:00AM-10:30AM: Pediatric Rheumatology – Clinical Poster I: JIA

9:00AM-10:30AM: Psychology/Social Sciences Poster

9:00AM-10:30AM: RA – Diagnosis, Manifestations, and Outcomes Poster II

9:00AM-10:30AM: RA – Etiology and Pathogenesis Poster

9:00AM-10:30AM: RA – Treatment Poster II

9:00AM-10:30AM: Reproductive Issues in Rheumatic Disorders Poster

9:00AM-10:30AM: Research Methodology Poster

9:00AM-10:30AM: SLE – Etiology and Pathogenesis Poster

9:00AM-10:30AM: SLE – Treatment Poster II

9:00AM-10:30AM: Spondyloarthritis Including PsA – Diagnosis, Manifestations, and Outcomes Poster II

9:00AM-10:30AM: Spondyloarthritis Including PsA – Treatment Poster II: Mixed

9:00AM-10:30AM: Systemic Sclerosis and Related Disorders – Clinical Poster I

9:00AM-10:30AM: Vasculitis – ANCA-Associated Poster II: Treatment Efficacy, Clinical Outcomes, Biomarkers

11:30AM-1:00PM: Plenary II

1:00PM-3:00PM: Epidemiology and Public Health Poster II

1:00PM-3:00PM: Fibromyalgia and Other Clinical Pain Syndromes Poster

1:00PM-3:00PM: Genetics, Genomics and Proteomics Poster

1:00PM-3:00PM: Imaging of Rheumatic Diseases Poster

1:00PM-3:00PM: Measures and Measurement of Healthcare Quality Poster

1:00PM-3:00PM: Osteoporosis and Metabolic Bone Disease – Basic and Clinical Science Poster

1:00PM-3:00PM: Patient Outcomes, Preferences, and Attitudes Poster II

1:00PM-3:00PM: Pediatric Rheumatology – Clinical Poster II: Connective Tissue Disease

1:00PM-3:00PM: RA – Diagnosis, Manifestations, and Outcomes Poster III

1:00PM-3:00PM: RA – Treatment Poster III

1:00PM-3:00PM: SLE – Diagnosis, Manifestations, and Outcomes Poster II: Manifestations

1:00PM-3:00PM: Spondyloarthritis Including PsA – Basic Science Poster

1:00PM-3:00PM: Spondyloarthritis Including PsA – Diagnosis, Manifestations, and Outcomes Poster III

1:00PM-3:00PM: Systemic Sclerosis and Related Disorders – Basic Science Poster

1:00PM-3:00PM: Systemic Sclerosis and Related Disorders – Clinical Poster II

1:00PM-3:00PM: Vasculitis – Non-ANCA-Associated and Related Disorders Poster II

Monday, November 14, 2022

11:30AM-1:00PM: Plenary III

1:00PM-3:00PM: (L07–L17) Late-Breaking Abstract Poster

1:00PM-3:00PM: Epidemiology and Public Health Poster III

1:00PM-3:00PM: Innate Immunity Poster: Basic and Translational Science

1:00PM-3:00PM: Late-Breaking Abstracts (L01–L06)

1:00PM-3:00PM: Metabolic and Crystal Arthropathies – Basic and Clinical Science Poster

1:00PM-3:00PM: Miscellaneous Rheumatic and Inflammatory Diseases Poster III

1:00PM-3:00PM: Muscle Biology, Myositis and Myopathies Poster II

1:00PM-3:00PM: Osteoarthritis – Clinical Poster

1:00PM-3:00PM: Pediatric Rheumatology – Clinical Poster III: Other

1:00PM-3:00PM: RA – Diagnosis, Manifestations, and Outcomes Poster IV

1:00PM-3:00PM: RA – Treatment Poster IV

1:00PM-3:00PM: Sjögren's Syndrome – Basic and Clinical Science Poster

1:00PM-3:00PM: SLE – Animal Models Poster

1:00PM-3:00PM: SLE – Diagnosis, Manifestations, and Outcomes Poster III: Outcomes

1:00PM-3:00PM: Spondyloarthritis Including PsA – Treatment Poster III: PsA

1:00PM-3:00PM: Systemic Sclerosis and Related Disorders – Clinical Poster III

1:00PM-3:00PM: T Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].